Innovative Industrial Properties (IIPR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Generated Q1 2025 revenues of $71.7 million and AFFO of $55.3 million, with net income attributable to common stockholders of $30.3 million, ending with over $220 million in liquidity.
Owns 110 properties in 19 states, focused on cannabis-related real estate, with 98.4% leased as of March 31, 2025, and a weighted-average lease term of 13.5 years.
Q1 2025 marked by tenant defaults (PharmaCann, 4Front, Gold Flora, TILT), leading to lease defaults, application of security deposits, and legal remedies.
Strategic shift underway to refresh tenant base, optimize occupancy, and improve financial stability and growth.
Repurchased $20 million of common stock and retired nearly $9 million of debt at a discount.
Financial highlights
Q1 2025 revenues were $71.7 million, down 6.5% sequentially and 5% year-over-year, mainly due to tenant defaults and lease terminations.
AFFO was $55.3 million ($1.94/share), a 13% decrease from Q4 2024 and 12% year-over-year.
Net income attributable to common stockholders was $30.3 million, down from $39.1 million in Q1 2024.
Applied $5.8 million of security deposits for rent payments from defaulted tenants; these deposits are now exhausted.
Declared dividends: $1.90 per common share and $0.5625 per Series A preferred share.
Outlook and guidance
Management expects the tenant refresh and retenting process to play out over the next 18–36 months amid continued challenges from tenant financial health, regulatory uncertainty, and market dynamics.
Confident in the ability to stabilize the portfolio and capitalize on new investment opportunities as market conditions evolve.
Liquidity expected to be sufficient through cash on hand, operations, and available credit.
Latest events from Innovative Industrial Properties
- 2025 revenue, AFFO, and net income strong; IQHQ investment and leasing drive future growth.IIPR
Q4 20256 Aug 2026 - Q2 2026 saw revenue and net income growth, strong liquidity, and strategic sector investments.IIPR
Q2 20264 Aug 2026 - Diversified REIT leverages triple-net leases and life science investments for strong, sustained growth.IIPR
Investor presentation3 Aug 2026 - Diversified REIT leverages triple-net leases and sector expertise for growth in cannabis and life sciences.IIPR
Company presentation3 Aug 2026 - Q2 revenue up 4% to $79.8M, net income $41.7M, AFFO $2.29/share, and dividend raised 4.4%.IIPR
Q2 20248 Jul 2026 - Q3 2024 revenue was $76.5M with 95.7% occupancy and strong liquidity despite industry headwinds.IIPR
Q3 20248 Jul 2026 - Q1 2026 revenue was $69M, but tenant defaults and debt maturity threaten ongoing viability.IIPR
Q1 20265 May 2026 - Diversified REIT with robust growth, strong balance sheet, and expanding life sciences exposure.IIPR
Investor presentation5 May 2026 - 2025 featured robust financials, strategic diversification, and strong governance ahead of key shareholder votes.IIPR
Proxy filing23 Apr 2026